Clinical trial
An open label phase II study to evaluate the efficacy and safety of induction and consolidation therapy with dasatinib in combination with chemotherapy in patients aged 55 years and over with philadelphia chromosome positive (PH+ or BCR-ABL+) acute lympho
To evaluate the efficacy of a dasatinib-based induction and consolidation therapy
| Category | Value |
|---|---|
| Study start date | 2007-06-07 |